Results from ex-vivo experiments provide evidence of wide alterations of CB1R and CB2R expression in several experimental models of multiple sclerosis (MS) and in patients affected by different clinical forms of MS [50,51,52,53,54,55]. The gene discussed is CNR1; the disease is myeloid sarcoma.